7+Years of programmes
MultiMedical disciplines
GlobalSpeaker network
TrustedBy academia & industry
From fundamental research to industrial translation — GSBG 2027 invites original contributions across the full breadth of biotechnology.
Synthetic biology has matured from artisanal pathway construction into a design-build-test-learn discipline backed by AI-guided enzyme engineering and high-throughput strain screening.
ExploreGene editing has crossed into the clinic with Casgevy (exa-cel) approved for sickle cell disease and beta-thalassemia, and in vivo programs from Verve Therapeutics (VERVE-102 for hypercholesterolemia) and Intellia (NTLA-2001 for ATTR amyloidosis, NTLA-2002 for HAE) reporting durable knockdown with single LNP-delivered doses.
ExploreTissue engineering is converging with high-resolution bioprinting, induced pluripotent stem cell biology, and decellularized scaffolds to produce functional tissue constructs at clinically relevant scales.
ExploreThe medical device frontier is increasingly defined by miniaturized, AI-enabled, and continuously sensing platforms.
ExploreComputational biology has been transformed by foundation models for protein structure (AlphaFold 3, RoseTTAFold All-Atom, ESMFold) and de novo design (RFdiffusion, Chroma), shifting drug discovery from screening to designing.
ExploreDrug delivery is the linchpin of modern therapeutics, with lipid nanoparticles (Acuitas, Genevant, Moderna SM-102) carrying mRNA and CRISPR payloads, and antibody-drug conjugates (Enhertu, Trodelvy, datopotamab deruxtecan) delivering cytotoxic warheads with unprecedented therapeutic indices.
ExploreGSBG 2027 is a global forum for pioneering research, clinical translation and cross-disciplinary dialogue across the full spectrum of biotechnology, genomics and bioengineering.
Across two days of keynotes, parallel technical tracks, poster sessions and focused workshops, we convene the brightest minds to chart the frontier of biotechnology — from laboratory science to clinical impact.
GSBG 2027 is more than a conference — it is a launchpad for your research, your clinical practice, and your next translational collaboration.
Hear first on breakthrough findings across 35 scientific sessions in biotechnology & bio-medical engineering.
Keynote, plenary and invited speakers from leading US and international institutions.
Connect with researchers, clinicians and industry leaders across 12+ countries — in one room, over two days.
All accepted abstracts published in the ISBN-allocated proceedings; selected papers invited to partner journals.
Best Paper, Best Poster and Young Investigator awards with global visibility and certificates of excellence.
Two days of curated networking and a gala dinner — attend on-site in the USA or stream every session live, worldwide.
Early-bird pricing available until July 14, 2026. All fees include the full two-day program, conference kit, lunches and networking events.
Mark these deadlines to stay ahead of abstract submission, registration and arrival.
Everything you need to submit abstracts, prepare presentations, and share GSBG 2027 with your colleagues.